158 related articles for article (PubMed ID: 25539284)
1. Novel investigational therapeutics for panic disorder.
Perna G; Schruers K; Alciati A; Caldirola D
Expert Opin Investig Drugs; 2015 Apr; 24(4):491-505. PubMed ID: 25539284
[TBL] [Abstract][Full Text] [Related]
2. Emerging drugs for panic disorder.
Perna G; Guerriero G; Caldirola D
Expert Opin Emerg Drugs; 2011 Dec; 16(4):631-45. PubMed ID: 21999303
[TBL] [Abstract][Full Text] [Related]
3. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
Ströhle A
Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
[TBL] [Abstract][Full Text] [Related]
4. Discontinued anxiolytic drugs (2009 - 2014).
Mandrioli R; Mercolini L
Expert Opin Investig Drugs; 2015 Apr; 24(4):557-73. PubMed ID: 25557457
[TBL] [Abstract][Full Text] [Related]
5. Emerging drugs for the treatment of anxiety.
Murrough JW; Yaqubi S; Sayed S; Charney DS
Expert Opin Emerg Drugs; 2015 Sep; 20(3):393-406. PubMed ID: 26012843
[TBL] [Abstract][Full Text] [Related]
6. Investigational drugs under development for the treatment of PTSD.
Ragen BJ; Seidel J; Chollak C; Pietrzak RH; Neumeister A
Expert Opin Investig Drugs; 2015 May; 24(5):659-72. PubMed ID: 25773140
[TBL] [Abstract][Full Text] [Related]
7. Stress responsive neurohormones in depression and anxiety.
Ströhle A; Holsboer F
Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacotherapy of panic disorder].
Bougerol T; Farisse J
Encephale; 1996 Dec; 22 Spec No 5():46-53. PubMed ID: 9138947
[TBL] [Abstract][Full Text] [Related]
9. Corticotropin releasing factor receptor antagonists for major depressive disorder.
Paez-Pereda M; Hausch F; Holsboer F
Expert Opin Investig Drugs; 2011 Apr; 20(4):519-35. PubMed ID: 21395482
[TBL] [Abstract][Full Text] [Related]
10. Novel investigational therapeutics for generalized anxiety disorder (GAD).
Schanzer B; Rivas-Grajales AM; Khan A; Mathew SJ
Expert Opin Investig Drugs; 2019 Nov; 28(11):1003-1012. PubMed ID: 31607187
[No Abstract] [Full Text] [Related]
11. New investigational drugs for the treatment of neuropathic pain.
Sałat K; Kowalczyk P; Gryzło B; Jakubowska A; Kulig K
Expert Opin Investig Drugs; 2014 Aug; 23(8):1093-104. PubMed ID: 24896842
[TBL] [Abstract][Full Text] [Related]
12. Drugs under early investigation for the treatment of bipolar disorder.
Konstantakopoulos G; Dimitrakopoulos S; Michalopoulou PG
Expert Opin Investig Drugs; 2015 Apr; 24(4):477-90. PubMed ID: 25704484
[TBL] [Abstract][Full Text] [Related]
13. Benzodiazepines for the treatment of panic disorder and generalized anxiety disorder: clinical issues and future directions.
Bradwejn J
Can J Psychiatry; 1993 Nov; 38 Suppl 4():S109-13. PubMed ID: 7905780
[TBL] [Abstract][Full Text] [Related]
14. A Novel Bio-Psychosocial-Behavioral Treatment Model of Panic Disorder.
Park SC; Kim YK
Psychiatry Investig; 2019 Jan; 16(1):4-15. PubMed ID: 30301303
[TBL] [Abstract][Full Text] [Related]
15. Investigational drugs for pruritus.
Benecke H; Lotts T; Ständer S
Expert Opin Investig Drugs; 2013 Sep; 22(9):1167-79. PubMed ID: 23815605
[TBL] [Abstract][Full Text] [Related]
16. Cholecystokinin and panic disorder: past and future clinical research strategies.
Bradwejn J; Koszycki D
Scand J Clin Lab Invest Suppl; 2001; 234():19-27. PubMed ID: 11713976
[TBL] [Abstract][Full Text] [Related]
17. The failure of anxiolytic therapies in early clinical trials: what needs to be done.
Stewart AM; Nguyen M; Poudel MK; Warnick JE; Echevarria DJ; Beaton EA; Song C; Kalueff AV
Expert Opin Investig Drugs; 2015 Apr; 24(4):543-56. PubMed ID: 25727478
[TBL] [Abstract][Full Text] [Related]
18. Efficacy studies of alprazolam in panic disorder.
Spiegel DA
Psychopharmacol Bull; 1998; 34(2):191-5. PubMed ID: 9640999
[TBL] [Abstract][Full Text] [Related]
19. Glutamate receptor antagonists with the potential for migraine treatment.
Ferrari A; Rustichelli C; Baraldi C
Expert Opin Investig Drugs; 2017 Dec; 26(12):1321-1330. PubMed ID: 29050521
[TBL] [Abstract][Full Text] [Related]
20. [Cortico-subcortical electrophysiological study during the effects of benzodiazepines in patients with panic disorders].
Guerrero Figueroa R; Heath RG; Escobar-Juyo A; Caballero-García G; Blanco-Castillo I
Rev Neurol; 2001 Feb 16-28; 32(4):321-7. PubMed ID: 11333385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
